share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Echevarria Joseph

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Echevarria Joseph

輝瑞 | 4:持股變動聲明-董事 Echevarria Joseph
美股sec公告 ·  04/27 01:24
牛牛AI助理已提取核心訊息
Joseph Echevarria, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Echevarria to Pfizer has not been specified, and there is no information provided on the number of shares held after the action.
Joseph Echevarria, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Echevarria to Pfizer has not been specified, and there is no information provided on the number of shares held after the action.
輝瑞公司 [PFE] 的舉報人約瑟夫·埃切瓦里亞於2024年4月25日參與了一筆交易。公告中沒有披露有關交易性質的具體細節,包括股票數量、交易價格和股票總價值。Echevarria與輝瑞的關係尚未具體說明,也沒有提供有關行動後持有的股票數量的信息。
輝瑞公司 [PFE] 的舉報人約瑟夫·埃切瓦里亞於2024年4月25日參與了一筆交易。公告中沒有披露有關交易性質的具體細節,包括股票數量、交易價格和股票總價值。Echevarria與輝瑞的關係尚未具體說明,也沒有提供有關行動後持有的股票數量的信息。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。